Antigen-induced positive selection and homeostasis of B lymphocytes in secondary lymphatic organs are, besides other factors, controlled by the B-cell receptor (BCR). 1 The IgM BCR complex consisting of two Ig heavy (m) and light chains as well as the signaling molecules Iga and Igb is first presented on the surface of immature B cells in the bone marrow. Here, the BCR is tested for binding to self in order to avoid generation of self-reactive B cells, since failure to establish tolerance during early B-cell development can cause antibody-mediated autoimmune diseases. Immature B cells migrate then as transitional (T1) B cells to the spleen where they develop into T2 B cells and further on develop into mature B cells. At this transition, BCR signaling is essential for survival, 2 whereby the strength of the BCR signal regulates development of immature B cells into B1-, B2-and marginal zone B cells. 3 The quality of the BCR signal is regulated in a developmental manner: BCR engagement by self-antigen prevents T1 B-cell maturation through clonal deletion, whereas encounter of the BCR in mature B cells initiates proliferation and, with specific costimulation, differentiation into plasma cells. 4 Since one B cell expresses the same BCR during its differentiation from immature to mature cell and the BCR is required for immature and mature B-cell homeostasis, 1, 5 a key question is how the BCR mediates three physiological outcomes, namely survival, differentiation or apoptosis. One possibility are different BCR signaling modes in immature and mature B cells. 4, 6 Calcium mobilization and tyrosine phosphorylation patterns differ qualitatively in immature and mature B lymphocytes 6, 7 but quantitative differences have also been reported. Specifically, transitional immature B cells in an autoreconstitution system responded to IgM stimulation at five times lower doses of anti-IgM antibodies than mature B cells. 7 This suggests that the BCR signaling threshold is regulated between immature and mature B cells, possibly by sequential expression of signaling molecules during B-cell development. 6, 8 Another possibility is different compartmentalization of the BCR in the plasma membrane. Many BCR signaling molecules are concentrated in cholesterol-dependent microdomains (lipid rafts) in the plasma membrane. Lipid rafts therefore represent essential platforms for BCR signaling. 9 Interestingly, in immature B-cell lines, the BCR appears to be excluded from lipid rafts. 10, 11 Moreover, primary immature, transitional B cells have lower amounts of cholesterol in their plasma membrane than mature B cells, explaining the failure of the BCR to become stabilized in lipid rafts upon BCR crosslinking in immature B cells. 12 Differences in the protein composition of lipid rafts between mature and immature B cells have also been proposed to account for the disability of the BCR to interact with lipid rafts. 13 We recently identified a novel potential signaling protein, Swiprosin-1, that is enriched in lipid rafts of two B-cell lines responding to BCR stimulation with apoptosis.
14 Swiprosin-1 has first been described and named in human CD8-positive T lymphocytes. 15 Here, we demonstrate a function of Swiprosin-1. Overexpression of Swiprosin-1 in the immature B-cell line WEHI231 enhanced spontaneous and BCR-induced apoptosis. In contrast, shRNA-mediated silencing of Swiprosin-1 suppressed apoptosis following BCR ligation. Finally, Swiprosin-1 regulated net cell growth of WEHI231 cells through control of spontaneous apoptosis. Our findings support the conclusion that Swiprosin-1 regulates apoptosis and influences BCR signaling in immature B cells.
Results
Structure and expression of Swiprosin-1. The aim of this study was to characterize Swiprosin-1. Swiprosin-1 is a 240 amino-acid protein with predicted and apparent molecular weights of 27 and 33 kDa, respectively.
14, 15 Comparison of amino-acid sequences revealed that mouse Swiprosin-1 (NM_025994) is almost identical to human (NM_024329) (91%) and rat orthologues (NM_001031648) (98%). Rat and human Swiprosin-1 are 93% identical (Figure 1a ). Primary and secondary structure analysis (Figure 1b) showed that Swiprosin-1 putatively contains four myristylation sites, lipid modifications known to play a role in association of proteins with lipid rafts, 16 three binding sites for SH3 domain containing proteins, two EF-hand domains and a coiled-coil domain at the C-terminus. These features could indicate a function for Swiprosin-1 as small adaptor protein involved in
To analyze the expression of Swiprosin-1, we performed Northern blot analysis. As predicted from the cDNA sequence, a Swiprosin-1 message of 2.4 kb length was detected in spleen, lung and liver with highest abundance in brain and lowest abundance in kidney and thymus ( Figure 1c) . We further analyzed expression of Swiprosin-1 during B-cell development. Semiquantitative RT-PCR analysis revealed that Swiprosin-1 is expressed throughout B-cell differentiation, with highest expression in immature bone marrow B cells (Figure 1d ). In contrast, Swiprosin-2, a close homolog, is expressed only in pro-B cells (our unpublished data). To test whether activation of mature B cells affects expression of Swiprosin-1, mature splenic B cells were stimulated with antiIgM F(ab) 2 /IL-4, LPS or anti-CD40/IL-4. Western blot analysis (Figure 1e) showed that there was no obvious change in Swiprosin-1 expression following stimulation for up to 96 h.
Involvement of Swiprosin-1 in immature B-cell apoptosis. We originally identified Swiprosin-1 in lipid rafts of the immature B-cell line WEHI231.
14 To characterize Swiprosin-1, we infected WEHI231 cells with a retrovirus encoding Myc-tagged Swiprosin-1 (pSw1Myc) or with empty virus, pMSCVpuro (pMSCV). Expression of Sw1myc was verified by western blotting with anti-Swiprosin-1 ( Figure 2a ) and anti-Myc antibodies (not shown). Initially, we observed a significant amount of dead cells in puromycin-resistant cultures transduced with pSwiMyc. To investigate whether this was due to apoptosis, we used an early marker, namely loss of the mitochondrial membrane potential (DC m ). 17 Cells were labeled with 3,3 0 -dihexyloxacarbocyanine iodide (DioC6), a fluorochrome that stains mitochondria in a DC m -dependent manner, 18 and with propidium iodide (PI), to identify secondary necrotic cells. This revealed an increased frequency of PI-negative cells with reduced DC m in pSwiMyc-transduced WEHI231 cells, but not in untransduced or pMSCV-transduced cells (Figure 2b ), indicating that Swiprosin-1 might induce apoptosis through the mitochondrial pathway. In immature, transitional B cells, BCR stimulation results in induction of apoptosis 4 and WEHI231 cells serve as a model system for this process. 19 To examine involvement of Swiprosin-1 in BCR-mediated apoptosis, we analyzed WEHI231wt, pMSCV-and pSw1Myc-transduced cells with AnnexinV (AnxV)/PI staining before and after BCR stimulation ( Figure 2d ) (representative analysis in Figure 2c ). BCR engagement led to an increase in early apoptotic (AnxV þ /PI À ) and secondary necrotic cells (AnxV þ /PI þ ) in the wt population (total of 17.6% after 20 h) (Figure 2d ). However, after 20 h, pSw1Myc-transduced WEHI231 cultures contained on the average 61% total apoptotic cells after BCR stimulation, that is 3.7-fold more apoptotic cells than in wt cells. After 20 h, pMSCV-transduced cells displayed on the average 35.1% of total apoptotic cells, equivalent to a twofold increase over wt cells. Although pMSCV-transduced cells showed increased apoptosis in this assay compared to wt cells, pSwiMyc-transduced cells were almost twice as apoptotic as pMSCV-transduced cells, indicating a specific Swiprosin-1 effect. When left unstimulated, pSwiMyctransduced WEHI231 cells were on the average more apoptotic (8%) after 20 h than pMSCV-transduced (4.9%) or wt cells (4.4%) (Figure 2d ). These results, together with the observation that pSwiMyc-transduced cells displayed a decreased DC m under normal culture conditions, indicated that overexpression of Swiprosin-1 starts an apoptotic program amplifying proapoptotic BCR signals in WEHI231 cells.
To confirm these data, we silenced Swiprosin-1 stably via expression of a Swiprosin-1 specific shRNA (pshSw1). The empty vector (pSuper; pSp) ( Figure 3a) and a vector expressing a scrambled shRNA (pScrambled; pScr) with the same nucleotide content as the Swiprosin-1-specific RNA (Figure 3b ) served as controls. After 20 h of stimulation, pshSw1-WEHI231 cells showed on the average 4.9% apoptotic cells in comparison to the pSp-WEHI231 cells and wt cells that exhibited 13 or 14.1% apoptotic cells, respectively (Figure 3a ). This effect was specific since control clones expressing the scrambled shRNA (pScr) exhibited more apoptotic cells than pshSw1 clones (Figure 3b ). Thus, it was not simply expression of shRNA that protected WEHI231 cells from apoptosis.
Since the decrease of DC m (Figure 2b ) pointed to activation of the central, caspase-dependent apoptotic pathway, 17 we investigated whether Swiprosin-1 induced caspase activation. In fact, pSwiMyc-transduced cells exhibited a prominent signal of the large fragment of caspase 7 (p20) (Figure 3c Since we observed spontaneous apoptosis in untreated pSwiMyc-transduced WEHI231 cells (Figure 2 ), we hypothesized that the amount of Swiprosin-1 protein could also affect net cell increase. Therefore, we analyzed cell growth of pSwiMyc-, pMSCV-, pSp-and pshSw1-WEHI231 cells ( Figure 5 ). Interestingly, pSwiMyc-transduced cultures grew slower than pMSCV-and pSp cells, whereas pshSw1 cells grew faster than pMSCV-and pSp cells. Thus, decreased expression of Swiprosin-1 promotes survival and results in increased WEHI231 populations.
Swiprosin-1 contributes to BCR-induced apoptosis but not to BCR-induced G1 arrest. Net cell growth can also be influenced by cell cycle regulation and in WEHI231 cells, treatment with anti-IgM induces growth arrest in G0/G1 phase. 21 Thus, we analyzed the impact of Swiprosin-1 on the cell cycle. Figure 6a displays a representative flow cytometric analysis of WEHI231wt cells with characteristic G1 arrest and an increase of cells with subdiploid (subG1; apoptotic) DNA content after BCR stimulation. 21 In the absence of antiIgM stimulation, pshSw1-WEHI231 cells in contrast to pSp-WEHI231 cells contained a decreased subG1 population and a slightly increased G2/M population after 24 h. After 48 h, only a decreased subG1 peak was visible ( Figure 6b ). In stark contrast, pSw1Myc-WEHI231 cells displayed increased subG1 populations and decreased G2/M populations both after 24 and 48 h compared to pMSCV cells (Figure 6d ). In the presence of stimulating anti-IgM antibody, pshSw1-WEHI231 cells showed a significantly reduced subG1 peak after 24 and 48 h, and increased G2/M populations when compared to pSp-WEHI231 cells (Figure 6c ). Conversely, both after 24 and 48 h, pSwiMyc-WEHI231 cells featured strongly increased subG1 populations, concomitant with an accelerated decrease of cells in G2/M (Figure 6e ). Of note here is that first, pshSw1-WEHI231 cells did undergo G0/G1 cell cycle arrest after anti-IgM stimulation ( Figure 6c ) and second, pSwiMyc-WEHI231 cells hardly arrested at G0/G1 but rather went directly into apoptosis ( Figure 6e ). Thus, BCR-induced G0/G1 arrest takes place also in the absence of Swiprosin-1, but with delayed onset. To verify these data, we analyzed expression of p27 Kip1 , a cyclin-dependent kinase inhibitor that becomes upregulated after BCR 21 In keeping with the results of the cell cycle analyses, p27 Kip1 was upregulated 2.2-, 1.9-and 1.8-fold in pSp-, pshSw1 and pMSCV-WEHI231 cells, but only 1.2-fold in pSwiMyc-WEHI231 cells, respectively (Figure 7a) . Thus, Swiprosin-1 overexpression enhances spontaneous and BCR-elicited apoptosis, the latter probably through acceleration of the G1-SubG1 transition. Conversely, downregulation of Swiprosin-1 protects WEHI231 cells from apoptosis, but not from BCR-induced G0/G1 arrest. However, pshSw1-WEHI231 cells do undergo apoptosis and G2/M arrest after g-irradiation (Supplementary Figure 1) .
Bcl-2 (BH) homology proteins, such as Bim or Bcl-xL, regulate apoptosis through formation of pro-or antiapoptotic heterodimers. Since Bim is pro-and Bcl-xL is antiapoptotic in primary immature and in WEHI231 B cells, 22, 23 we next examined their abundance. Bcl-xL was roughly three-fold decreased in WEHI231 cells overexpressing Swiprosin-1 1 and 6) , pSw1Myc expressing-(pSw1Myc#19, lanes 2 and 7), Swiprosin silenced-(pshSw1 #2, lanes 3 and 8) and control WEHI231 clones (pMSCV #36, lanes 4 and 9, and pSp #2, lanes 5 and 10) were left untreated (medium) or stimulated with anti-IgM for 18 h. Cell lysates were analyzed by western blotting with caspase 7-specific antibody. Pro-casp 7: procaspase 7, casp 7 (p20): cleaved caspase 7. Molecular mass standards (kDa) are indicated on the left
(calculation based on dilution analysis; Figure 7b ). We corroborated these results by semiquantitative RT-PCR analysis where we observed a reduction in Bcl-xL mRNA (note that Bcl-2 mRNA was not changed; data not shown).
Conversely, Bcl-xL protein was on the average three-fold more abundant in Swiprosin-1-silenced cells compared to control clones (Figure 7c ). In contrast, proapoptotic Bim protein was not enhanced (Figure 7b ). Taken together, these results indicate that Swiprosin-1 abundance regulates Bcl-xL amounts reciprocally on the transcriptional level and thereby influences proapoptotic BCR signaling.
Swiprosin-1 is involved in nuclear factor jB signaling. The BCR activates the canonical nuclear factor kB (NF-kB) pathway where phosphorylation and subsequent degradation of inhibitors of NF-kB (IkB) lead to unmasking of NF-kB nuclear localization sequences and nuclear import of p50/p65 NF-kB heterodimers. 24, 25 Bcl-xL is a target gene of the canonical NF-kB pathway 26 and thus, cells devoid of Swiprosin-1 should positively regulate NF-kB in response to BCR stimulation. Indeed, BCR stimulation of pshSw1-WEHI231 cells induced strong IkB-a phosphorylation (Figure 8a ), which was not observed in control cells or in Swiprosin-1-overexpressing cells (Figure 8b-d) . Concomitantly, BCR-induced IkB-a degradation was enhanced in pshSw1-WEHI231 cells (Figure 8e ). In contrast, BCRinduced, transient p42/44-MAPK/Erk (mitogen-activated protein kinase/extracellular signal-regulated kinase) activation was similar in all cell lines examined (Figure 8 ). Collectively, our data suggest that Swiprosin-1 is part of the BCR signaling pathway and plays a role as negative regulator of the canonical NF-kB-activating branch. In support of this, we observed constitutive colocalization of a Swiprosin-1-EGFP fusion protein with the BCR in unstimulated cells, and partial cocapping with the BCR in BCR-stimulated WEHI231 cells (Supplementary Figure 2) .
If decreased NF-kB activity and decreased abundance of Bcl-xL were responsible for increased apoptosis of pSwiMyctransduced WEHI231 cells, activation of NF-kB should reverse this effect. Coincubation of pSwiMyc-transduced WEHI231 cells with agonistic anti-IgM mAb plus NF-kBinducing stimuli of B cells, namely BAFF (B-cell activating factor of the TNF family), 26 anti-CD40 mAb 27 and LPS (lipopolysaccharide), 24 alleviated apoptosis in pSwiMyctransduced cells to that of the control cells (pMSCV) (Figure 9a ). LPS pretreatment also reduced cell death induced by transient transduction of WEHI231 cells with the GFP-encoding retroviral vector pCru5-Sw1myc-IRES-GFP (9.4-3.6% after 24 h, 64-48.9% after 48 h), but hardly cell death in empty vector (pCru5-IRES-GFP)-transduced cells (Figure 10a ), but do contain immature, T1 B cells of the IgM high /IgD low phenotype, the target of negative BCR selection. 2 To retrovirally transduce primary B cells efficiently, entry into the cell cycle is necessary and best achieved by preactivating freshly isolated primary B cells with LPS. After BCR engagement, we detected an increase in the frequency of apoptotic cells (AnxV positive) from 38 to 57% in pSw1Myc-transduced cultures. BCR engagement also increased the frequency of apoptotic cells in primary cultures transduced with the GFP control vector ( Figure  10b) . However, the difference in the frequencies before and after BCR engagement was clearly smaller in control vectortransduced cells than in pSw1Myc-transduced cells and changed after addition of anti-IgM antibodies only from 55 to 61%. Vice versa, the frequency of live cells decreased significantly after BCR engagement in pSwiMyc-transduced cultures from 61 to 42%, but in control vector-transduced cultures only from 44 to 39%. Thus, Swiprosin-1 appears to amplify proapoptotic BCR signals not only in transformed B-lymphoma cells but also in primary B cells.
Discussion
Here we report a function of the novel adaptor protein Swiprosin-1 (synonym: Efhd2; www.ensembl.org): Swiprosin-1 regulates specifically apoptosis, but not cell cycling, in an immature B-cell line. During B-cell differentiation and the humoral immune response, regulation of apoptosis is extremely important. For example, only about 3% of the new B cells generated daily reach the long-lived B-cell pool in the periphery, 2 and apoptosis controls the pool of activated plasma blasts and selection in germinal centers.
Despite being proapoptotic in an immature B-cell line, Swiprosin-1 is expressed in similar amounts in all murine B-cell lines examined (not shown) and in resting and activated splenic B cells. Thus, there must be mechanisms regulating Swiprosin-1 function. We exclude interactions with Swiprosin-2 (Efhd1) because during B-cell differentiation, Swiprosin-2 is only expressed in pro-B cells (unpublished data). Since Swiprosin-1 is likely involved in EGF receptor signaling 28 and is not exclusively expressed in lymphoid tissue, it probably functions in a cell-type-specific manner. This may be due to different subcellular localization, sequential expression of interacting proteins or cell-type-specific post-translational modifications. Accordingly, Swiprosin-1 was enriched in lipid rafts of two cell lines prone to BCR-induced apoptosis in contrast to apoptosis-insensitive CH27 B cells. 14 The amplifying effect of Swiprosin-1 on BCR-induced cell death was reversed by LPS, anti CD40 and BAFF (Figure 9 ). LPS/TLR (toll like receptor)-4 signals might counteract Swiprosin-1 signals through sustained antiapoptotic activation of NF-kB. 24 In keeping with this idea, Bcl-xL, an antiapoptotic NF-kB target gene, was upregulated in WEHI231 cells in which Swiprosin-1 was silenced and downregulated in WEHI231 cells overexpressing Swiprosin-1. These findings are coherent with the notion that, like Swiprosin-1, Bcl-xL abundance regulates BCR-induced apoptosis, but not cell cycle arrest. 27 Since first, Swiprosin-1 expression is highest in immature, bone-marrow derived B cells and Bcl-xL is downregulated in immature B cells, Overexpression of Swiprosin-1 led to reduced DC m and caspase 7 cleavage but caspases do not appear to be directly involved in BCR-induced apoptosis in WEHI231 cells. 27 Thus, the possibility that overexpression of Swiprosin-1 activates the cytosolic phospholipase A2 (PL A2)/cathepsin pathway 27 in WEHI231 cells is not excluded here. However, we exclude upregulation of proapoptotic Bim and altered Erk signaling as reasons for Swiprosin-1-enhanced cell death because alteration of Swiprosin-1 expression did not affect Erk activation (0-60 min) or Bim expression. Instead, we observed increased IkB-a phosphorylation and degradation in pshSw1-WEHI231 cells. Antigen-induced BCR signals stimulate the canonical NF-kB pathway, 25 mediated through the PLCg2/protein kinase Cb (PKCb)/Carma-1 cascade. 31 Since silencing of Swiprosin-1 enhanced BCR-induced IkB-a degradation, we suggest that Swiprosin-1 is part of the NF-kB-activating branch of the BCR pathway. Therefore, downregulation of Swiprosin-1 in mature B cells could allow the BCR to trigger the PLCg2/PKCb/Carma-1 pathway for 'immunogenic' signaling. 31 In summary, Swiprosin-1 modulates spontaneous and BCR-induced apoptosis very likely through NF-kB, Bcl-xL, changes in DC m and activation of post-mitochondrial effector proteases.
Regulation of the lifespan of immature B cells through BCR signaling thresholds has been proposed by several groups (reviewed by Noelle and Erickson 32 ) and may be determined genetically. 33 Interestingly, the murine Swiprosin-1 gene is localized only 10 Mb away from the peak marker D4Mit33 in a murine systemic lupus erythematodes susceptibility locus on chromosome 4. 33 An intriguing question therefore is whether Swiprosin-1 is regulated under inflammatory conditions? Indeed, Swiprosin-1 appears to be downregulated in PBMC of human rheumatoid arthritis patients. 34 Downregulation of Swiprosin-1 could therefore not only affect normal B-cell 
32
Although WEHI231 cells serve as model system for BCRinduced apoptosis, this cell line is still a murine B-lymphoma cell line. 19 Since silencing of Swiprosin-1 accelerated net cell growth in WEHI231 cells, reduced Swiprosin-1 protein might contribute to growth of lymphomas, especially because mutations in pro/antiapoptotic genes or enhanced NF-kB activity often precede secondary mutations affecting cell cycle regulation in aggressive lymphomas. 25 In summary, our data support the conclusion that Swiprosin-1 determines lifespan and sets the threshold for BCR signaling in B cells, probably predominantly in immature B cells. The generation of mice with a Swiprosin-1-null allele will clarify this issue.
Materials and Methods
Antibodies and other reagents. Anti-Swiprosin-1 antiserum was described previously.
14 Rabbit anti-Erk1 and mouse monoclonal anti-Bip were purchased from BD Bioscience (New Jersey, USA), anti-Actin and anti-Cofillin were from Sigma (Deisenhofen, Germany). Rabbit anti-Caspase 7, anti-Caspase 3, anti-p27 Kip1 (kind gift of Dr. Jean Schneickhardt), phosphorylation-specific antibodies, anti-IkBa and anti-Bim were purchased from Cell Signaling Technology (Danvers, MA, USA). Goat anti-mouse IgM was obtained from Southern Biotechnology, goat anti-mouse IgM F(ab) 2 fragments were from Jackson Immunolaboratories (distributed by Dianova, Hamburg, Germany). Rat anti-CD40 (1C10) 35 and anti IgM (b.7.6) 36 were purified from hybridoma supernatants. IL-4 was from Strathmann (Hamburg, Germany). LPS was purchased from Sigma and oligonucleotides were ordered from MWG Biotech (Ebersberg, Germany). Flag-tagged BAFF was purchased from Alexis Biochemicals (Grünberg, Germany).
Cells. Phoenix-E packaging cells were cultured in DMEM supplemented with 10% heat inactivated FBS (HI-FBS), 1 mM sodium pyruvate, 50 mM b-mercaptoethanol (b-ME) and 100 mg/ml penicillin-streptomycin (all from Invitrogen, Karlsruhe, Germany) at 371C and 7.5% CO 2 . WEHI231 cells 19 and primary murine B cells were cultured in RPMI 1640 medium supplemented with 10% HI-FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 50 mM b-ME and 100 mg/ml penicillin-streptomycin (R10 medium) at 371C and 5% CO 2 . Primary murine B cells were negatively selected from spleens of C57BL/6 mice using anti-CD43 microbeads (Miltenyi Biotec, Bergisch-Gladbach, Germany) and were typically 495% pure. Pro-B cells (c-kit
þ , sIgM þ ) were isolated from bone marrow of 20 C57BL/6 mice and sorted in a MoFlo cell sorter (Dako Cytomation, Glostrup, Denmark). Pro-B cells purified in this manner were 98.68% pure, pre-B cells were 97.7% pure and immature B cells were 81% pure (data not shown). For infection, B cells were isolated from spleens of 16-week-old C57BL/6 mice using positive selection with CD19 magnetic beads (Miltenyi Biotec). Cells were stimulated with 10 mg/ml goat anti-mouse IgM F(ab) 2 / 100 U/ml IL-4, 10 mg/ml anti-CD40/IL-4 (100 U/ml) or LPS (10 mg/ml).
Northern blot analysis. Organs of a C57Bl/6 mouse were prepared, frozen in liquid nitrogen, homogenized and total RNA was prepared. In total, 10 mg RNA per lane were electrophoretically separated, blotted onto nylon membrane (GeneScreen Plus, PerkinElmer, Zaventems, Belgium) and probed overnight with cDNA and plasmids. Murine Swiprosin-1 cDNA was amplified from WEHI231 RNA using the one-step RT-PCR kit (Qiagen, Hilden, Germany). Forward (5 0 -ATGGCCACGGACGAGTTGG-3 0 ) and reverse (5 0 -CTACTTGAACGTGGACTG CAGC-3 0 ) primers were annealed at 601C and the reaction included 35 cycles. The product was cloned into pCR2.1 (Invitrogen) and sequenced. To construct a C-terminally Myc-tagged Swiprosin-1 (Sw1-Myc), murine Swiprosin-1 cDNA was amplified from the pCR2.1-Sw1 vector using Pfu DNA polymerase (Stratagene, La Jolla, USA), with specific forward (5 0 -GATCGGATCCACCATGGCCACGGACG AGTTGGC-3 0 ) and reverse (5 0 GATCGCGGCCGCCTACAGATCCTCTTCTTCTG AGATGAGTTTTTGTTCCTTGAACGTGGACTG-3 0 ) primers. The product was cloned into pCR2.1 and sequenced. The retroviral vector pMSCVpuro-Sw1Myc was constructed by cloning the EcoRI Swiprosin-1-Myc fragment isolated from pCR2.1 vector into pMSCVpuro (Clontech, Mountain View, USA). To construct a GFP-expressing retrovirus, the Swiprosin-1-Myc cDNA from the pSw1Myc vector was excised with XhoI and NotI and cloned into pCru5-IRES-GFP 37 to obtain pCru5-Sw1Myc-IRES-GFP. A Swiprosin-1-EGFP fusion protein was constructed by PCR with Pfu DNA polymerase, using Swiprosin-1 cDNA and XhoI and BamH1 flanked, Swiprosin-1-specific primers (see above). The PCR product was subcloned into pEGFP-N1 (Clontech), sequenced and finally cloned into pMSCV-Puro using BglII/ HpaI restriction sites. EGFP cDNA was cut out of pEGFP-N1 with BamH1/Not1, subcloned into pCR2.1, cut out again with BglII/Xho1 and finally cloned into pMSCVPuro to generate pMSCV-GFP.
Retroviral infection of WEHI231 and primary B cells. Viral supernatants were obtained by standard methods. Then, 5 Â 10 5 WEHI231 cells were incubated for 3.5 h with 10 mg/ml polybrene (Sigma) in 1 ml of retroviral supernatant at 1671 Â g and 331C. After infection, cells were cultured for 24 h in fresh medium. Tansduction was repeated 24 h later and another 24 h later, cells were selected with puromycin. Stably infected cells were maintained in medium supplemented with 0.4 mg/ml puromycin. Single cell clones were generated out of resistant bulk cultures by limiting dilution and chosen based on equal surface IgM expression. Swiprosin-1-EGFP-and EGFP-expressing WEHI231 cells were not subcloned. For transient infections, isolated primary B cells and WEHI231 cells were infected with pCru5-IRES-GFP or pCru5-Sw1myc-IRES-GFP plasmids only once, following 36 h LPS stimulation (10 mg/ml). Infection efficiencies were 10-20% for mature B cells.
Stable knockdown of Swiprosin-1 in WEHI231 cells. The 19-nucleotide sequence 5 0 -GCGTTTGCCTCAGCGGATA-3 0 (residues 2005-2023 in the murine Swiprosin-1 cDNA sequence, GenBank accession number NM_025994) was inserted as an inverted repeat into the expression vector pSUPERPuro. 38 As a control, a scrambled shRNA with the same nucleotide content but without significant database match was created and inserted similarly to generate pSUPERPuroscrambled (5 0 -TGGCTCAACGCTTCGAGTG-3 0 ). Then, 2 Â 10 6 WEHI231 cells were transfected with 2 mg of vector by nucleofection according to the manufacturer's instructions (Amaxa, Cologne, Germany). At 24 h after transfection, cells were selected with 0.4 mg/ml puromycin in R10 medium. Stable clones were obtained by limiting dilution out of resistant bulk cultures.
Apoptosis assays, cell cycle analysis and growth curves Apoptosis assays. 1 Â 10 5 cells in 0.2 ml were plated in 48-well plates in triplicate and left either unstimulated or stimulated with 10 mg/ml goat anti-mouse IgM F(ab) 2 -fragment. Cells were washed with AnnexinV-binding buffer (25 mM HEPES, 140 mM NaCl, 2.5 mM CaCl 2 , pH 7.2) and incubated with 100 ml AnnexinVbinding buffer and recombinant chicken AnnexinV conjugated to FITC (Responsif, Erlangen, Germany) for 20 min at room temperature Samples were then filled up with 400 ml AnnexinV-binding buffer including 1 mg/ml propidium iodide (PI).
14 For analysis of the DC m , 18 cells were plated in triplicate for 24 h as above. DioC6 (80 nM) was added for 20 min, cells were washed with cold PBS and resuspended in 500 ml cold PBS including 1 mg/ml PI. After infection of cells with the pCru5 constructs, cells were washed once with AnnexinV-binding buffer and filled up with 500 ml AnnexinV-binding buffer in the presence of 200 nM TO-PRO-3 iodide (642/ 661 nm) (Invitrogen). Cells were analyzed immediately in a FACSCalibur flow cytometer (Becton Dickinson) using CELLQuest software (BD Biosciences). Cell cycle analysis. Cells were plated as for apoptosis assays, pelleted by centrifugation and resuspended in 500 ml hypotonic PI solution containing 50 mg/ml PI, 0.1% sodium citrate and 0.1% Triton X-100, 39 After 2 h on ice, samples were analyzed with a FACSCalibur flow cytometer (BD Biosciences). Growth curves. 1 Â 10 5 cells in 1.0 ml R10 medium were plated in 24-well plates in duplicates. At the indicated time points, 1 ml cell suspension was pelleted by centrifugation and resuspended in 200 ml PBS. Then, 200 ml fluorescent beads were added according to the manufacturer's instructions (FLOW-COUNTt Beckman Coulter, USA). Living cells were defined by forward/side scatter gating with a FACSCalibur flow cytometer (BD Biosciences) and the absolute cell number was determined. Generally, 24 h before all assays, dead cells were removed by Ficoll gradient and seeded at 0.5 Â 10 6 cells/ml.
Western blot analysis. Cells were washed in PBS and lysed in RIPA lysis buffer. Equal amounts of protein were separated by SDS-PAGE 40 followed by semi-dry transfer onto Protran nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany), blocked, probed and developed as described previously. 
